NCT06276829

Brief Summary

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls. Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
Last Updated

February 26, 2024

Status Verified

February 1, 2024

Enrollment Period

3.2 years

First QC Date

February 18, 2024

Last Update Submit

February 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • LDH/albumin ratio

    February 2020 and April 2023

Study Arms (2)

Behçet's Disease

Diagnostic Test: LDH/albumin ratio

healthy individuals

Diagnostic Test: LDH/albumin ratio

Interventions

LDH/albumin ratioDIAGNOSTIC_TEST

LDH/Albumin ratios of patient and control groups were recorded.

Behçet's Diseasehealthy individuals

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 349 subjects, including 160 patients with Behçet's disease and 189 healthy controls

You may qualify if:

  • Patients with Behçet's disease aged 18-69

You may not qualify if:

  • younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erdal Pala

Erzurum, 25240, Turkey (Türkiye)

Location

Related Publications (1)

  • Pala E, Bayraktar M. Lactate dehydrogenase to albumin ratio as a convenient parameter for predicting the severity of Behcet disease: a cross-sectional study. BMC Immunol. 2026 Jan 7;27(1):1. doi: 10.1186/s12865-025-00706-7.

MeSH Terms

Conditions

Behcet Syndrome

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesVasculitisVascular DiseasesCardiovascular DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Vascular

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Skin and Venereal Diseases

Study Record Dates

First Submitted

February 18, 2024

First Posted

February 26, 2024

Study Start

February 1, 2020

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

February 26, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations